{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:41:17Z","timestamp":1760982077130},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,5,12]],"date-time":"2007-05-12T00:00:00Z","timestamp":1178928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00115-007-2277-1","type":"journal-article","created":{"date-parts":[[2007,5,10]],"date-time":"2007-05-10T09:53:46Z","timestamp":1178790826000},"page":"1052-1057","source":"Crossref","is-referenced-by-count":5,"title":["Demenz mit Lewy-K\u00f6rperchen"],"prefix":"10.1007","volume":"78","author":[{"given":"M.","family":"Omerovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.J.","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,5,12]]},"reference":[{"key":"2277_CR1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/gps.389","volume":"16","author":"Aarsland","year":"2001","unstructured":"Aarsland D, Ballard C, Larsen JP, McKeith I (2001) A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson\u2019s disease with and without dementia. Int J Geriatr Psychiatry 16: 528\u2013536","journal-title":"Int J Geriatr Psychiatry"},{"key":"2277_CR2","first-page":"879","volume":"152","author":"Baba","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH et al. (1998) Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 152: 879\u2013884","journal-title":"Am J Pathol"},{"key":"2277_CR3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/01.WNL.0000036908.39696.FD","volume":"59","author":"Ballard","year":"2002","unstructured":"Ballard CG, Aarsland D, McKeith IG et al. (2002) Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 59: 1714\u20131720","journal-title":"Neurology"},{"key":"2277_CR4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/1531-8249(200012)48:6<868::AID-ANA7>3.0.CO;2-0","volume":"48","author":"Ballard","year":"2000","unstructured":"Ballard C, Piggott M, Johnson M et al. (2000) Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann Neurol 48: 868\u2013876","journal-title":"Ann Neurol"},{"key":"2277_CR5","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K et al. (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308\u20132314","journal-title":"Neurology"},{"key":"2277_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201eMini-Mental State\u201c: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189\u2013198","journal-title":"J Psychiatr Res"},{"key":"2277_CR7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/jnnp.62.3.243","volume":"62","author":"Gnanalingham","year":"1997","unstructured":"Gnanalingham KK, Byrne EJ,Thornton A et al. (1997) Motor and cognitive function in Lewy body dementia: comparison with Alzheimer\u2019s and Parkinson\u2019s diseases. J Neurol Neurosurg Psychiatry 62: 243\u2013252","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2277_CR8","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1212\/WNL.52.9.1839","volume":"52","author":"Heyman","year":"1999","unstructured":"Heyman A,Fillenbaum GG, Gearing M et al. (1999) Comparison of Lewy body variant of Alzheimer\u2019s disease with pure Alzheimer\u2019s disease. Neurology 52: 1839\u20131844","journal-title":"Neurology"},{"key":"2277_CR9","first-page":"214","volume":"18","author":"Jellinger","year":"1999","unstructured":"Jellinger KA (1999) The frequency of Lewy bodies in a consecutive autopsy series. Clin Neuropathol 18: 214\u2013215","journal-title":"Clin Neuropathol"},{"key":"2277_CR10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/(SICI)1099-1166(200004)15:4<338::AID-GPS119>3.0.CO;2-U","volume":"15","author":"Lanct\u00f4t","year":"2000","unstructured":"Lanct\u00f4t KL, Herrmann N (2000) Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry 15: 338\u2013345","journal-title":"Int J Geriatr Psychiatry"},{"key":"2277_CR11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/WNL.43.10.1927","volume":"43","author":"Langlais","year":"1993","unstructured":"Langlais PJ, Thal L, Hansen L et al. (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer\u2019s disease with and without Lewy bodies. Neurology 43: 1927\u20131934","journal-title":"Neurology"},{"key":"2277_CR12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/(SICI)1099-1166(199808)13:8<516::AID-GPS810>3.0.CO;2-O","volume":"13","author":"Lebert","year":"1998","unstructured":"Lebert F, Pasquier F, Souliez L et al. (1998) Tacrine efficacy in Lewy body dementia. Int J Geriatr Psychiatry 13: 516\u2013519","journal-title":"Int J Geriatr Psychiatry"},{"key":"2277_CR13","unstructured":"Lewy FH (1912) Paralysis agitans: I. Pathologische Anatomie. In: Lewandowsky M (Hrsg) Handbuch der Neurologie. Vol 3. Springer, Berlin, S\u00a0920\u2013933"},{"key":"2277_CR14","doi-asserted-by":"crossref","unstructured":"McKeith et al. (2005) Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium Neurology 65: 1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1"},{"key":"2277_CR15","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","volume":"356","author":"McKeith","year":"2000","unstructured":"McKeith IG, Del Ser T, Spano PF et al. (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356: 2031\u20132036","journal-title":"Lancet"},{"key":"2277_CR16","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","volume":"47","author":"McKeith","year":"1996","unstructured":"McKeith IG, Galasko D, Kosaka K et al. (1996) Consensus guidlines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 47: 1113\u20131124","journal-title":"Neurology"},{"key":"2277_CR17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1017\/S0033291700038484","volume":"22","author":"McKeith","year":"1992","unstructured":"McKeith IG, Perry RH, Fairbairn AF et al. (1992) Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med 22: 911\u2013922","journal-title":"Psychol Med"},{"key":"2277_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00002093-199040200-00003","volume":"4","author":"Perry","year":"1990","unstructured":"Perry EK, Marshall E, Perry RH et al. (1990) Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 4: 87\u201396","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2277_CR19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1991.tb00217.x","volume":"640","author":"Perry","year":"1991","unstructured":"Perry EK et al. (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson\u2019s disease, and Alzheimer\u2019s disease. Ann N Y Acad Sci 640: 197\u2013202","journal-title":"Ann N Y Acad Sci"},{"key":"2277_CR20","doi-asserted-by":"crossref","unstructured":"Perry RH, McKeith IG, Perry EK (1996) Introduction. In: Perry R, McKeith I, Perry E (eds) Dementia with Lewy bodies. Cambridge Univ Press, Cambridge, pp\u00a01\u20135","DOI":"10.1017\/CBO9780511601187.004"},{"key":"2277_CR21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000017260","volume":"11","author":"Querfurth","year":"2000","unstructured":"Querfurth HW, Allam GJ, Geffroy MA et al. (2000) Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial. Dement Geriatr Cogn Disord 11: 314\u2013321","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2277_CR22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","volume":"15","author":"Samuel","year":"2000","unstructured":"Samuel W, Caligiuri M, Galasko D et al. (2000) Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry 15: 794\u2013802","journal-title":"Int J Geriatr Psychiatry"},{"key":"2277_CR23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1041610298005341","volume":"10","author":"Shea","year":"1998","unstructured":"Shea C, MacKnight C, Rockwood K (1998) Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int Psychogeriatr 10: 229\u2013238","journal-title":"Int Psychogeriatr"},{"key":"2277_CR24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/jnnp.67.2.209","volume":"67","author":"Shiozaki","year":"1999","unstructured":"Shiozaki K, Iseki E, Uchiyama H et al. (1999) Alterations ofmuscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 67: 209\u2013213","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2277_CR25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U","volume":"15","author":"Shulman","year":"2000","unstructured":"Shulman KI (2000) Clock-drawing: Is it the ideal cognitive screening test? Int J Geriatr Psychiatry 15:548\u2013561","journal-title":"Int J Geriatr Psychiatry"},{"key":"2277_CR26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1176\/appi.neuropsych.16.4.409","volume":"16","author":"Simard","year":"2004","unstructured":"Simard M, Reekum R van (2004) The acetylcholinesterase inhibitors for treatment of cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci Fall 16: 409\u2013425","journal-title":"J Neuropsychiatry Clin Neurosci Fall"},{"key":"2277_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","volume":"13","author":"Wesnes","year":"2002","unstructured":"Wesnes KA, McKeith IG, Ferrara R et al. (2002) Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement Geriatr Cogn Disord 13: 183\u2013192","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2277_CR28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ageing\/afi190","volume":"34","author":"Zaccai","year":"2005","unstructured":"Zaccai J, McCracken C, Brayne C (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34: 561\u2013566","journal-title":"Age Ageing"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2277-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-007-2277-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-007-2277-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:08:28Z","timestamp":1558573708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-007-2277-1"}},"subtitle":["Besserung unter Therapie mit einem Acetylcholinesteraseinhibitor"],"short-title":[],"issued":{"date-parts":[[2007,5,12]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s00115-007-2277-1","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,12]]}}}